When is the next results date for Akums Drugs & Pharmaceuticals Ltd?
2026-05-13 23:17:38The next results date for Akums Drugs & Pharmaceuticals Ltd is scheduled for 14 May 2026....
Read More
Akums Drugs & Pharmaceuticals Ltd is Rated Hold
2026-04-24 10:10:03Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAkums Drugs Gains 5.90%: Technical Upgrades and Valuation Drive Momentum
2026-04-18 10:02:01Key Events This Week Apr 13: Mojo Grade upgraded to Hold on improved technicals and valuation Apr 15: Stock surges 3.99% amid bullish momentum confirmation Apr 16: Continued gains with 0.92% rise supported by technical indicators Apr 17: Slight profit-taking closes week at Rs.545.90 (-0.82%) Week OpenRs.524.45 Week Close</d...
Read More
Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades
2026-04-13 08:04:45Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a series of positive technical indicator signals. This development comes alongside an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the small-cap pharmaceuticals sector.
Read MoreAkums Drugs & Pharmaceuticals Ltd Gains 4.60%: 3 Key Technical Signals Driving the Week
2026-04-11 10:00:56Key Events This Week 6 Apr: Week opens at Rs.492.85 7 Apr: Technical momentum shifts to mildly bearish amid mixed market signals 9 Apr: Momentum shifts to sideways trend with a 3.19% intraday gain 10 Apr: Golden Cross formation signals potential bullish breakout; stock closes at Rs.515.50 (+4.84%) Week OpenRs.492.85 Week Cl...
Read More
Golden Cross Forms in Akums Drugs & Pharmaceuticals Ltd — Mixed Technical Signals Demand Caution
2026-04-10 18:00:39The 50-day moving average has crossed above the 200-day moving average for Akums Drugs & Pharmaceuticals Ltd, signalling a golden cross on 10 Apr 2026. Yet, the broader technical and fundamental picture presents a nuanced view that tempers the enthusiasm often associated with this crossover — is this a reliable signal or a misleading indicator for investors?
Read More
Akums Drugs & Pharmaceuticals Ltd is Rated Sell
2026-04-09 10:10:32Akums Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Akums Drugs & Pharmaceuticals Ltd Surges 7.07% to Day's High of Rs 500.25 — Outperforms Sector by 7.34 Percentage Points
2026-04-01 16:01:04The Sensex rose 1.65% while Akums Drugs & Pharmaceuticals Ltd surged 7.07% on 01 Apr 2026, marking a 7.34 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which touched an intraday high of Rs 500.25 amid a broadly mixed market backdrop.
Read More
Akums Drugs & Pharmaceuticals Ltd is Rated Sell
2026-03-29 10:10:26Akums Drugs & Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Jun-2026 | Source : BSENewspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividend
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10-Jun-2026 | Source : BSEIntimation of Schedule of the investor/analysts meets
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
09-Jun-2026 | Source : BSEIntimation of Schedule of the Investor/Analyst Meet
Corporate Actions
No Upcoming Board Meetings
Akums Drugs & Pharmaceuticals Ltd has declared 50% dividend, ex-date: 03 Jul 26
No Splits history available
No Bonus history available
No Rights history available